Navigation Links
Janssen, J&J Innovation, VIB, KU Leuven and UZ Leuven join forces to combat neurological diseases

Stellar, the collaboration between Janssen, J&J Innovation, VIB, KU Leuven and UZ Leuven, is launched to overcome the inefficiencies in translating basic molecular insights to diagnostics and therapeutics for neurodegenerative diseases. Janssen and Johnson & Johnson Innovation are committing up to 5 million Euros for this project over a five-year period. They will sponsor academic research projects from VIB, KU Leuven and UZ Leuven.

"Developing a new drug takes lots of time, especially for complex diseases such as Alzheimer's. We are convinced that we can increase the chance of success if we, as a research institute, join forces with a pharmaceutical company like Janssen," Johan Cardoen (Managing Director VIB).

"At Janssen Research & Development, we are deeply committed to patients with neurodegenerative diseases and to the health care professionals who care for them," said Husseini Manji, MD, Global Head, Neuroscience. "We believe that collaboration with external innovators is essential to drive the types of discoveries that will bring forth the treatments of tomorrow for neurodegenerative diseases."

"At Johnson & Johnson Innovation, accelerating the most promising early-stage science in collaboration with leading academic centres around the world is how we will continue to make improvements in the health and happiness of people worldwide," commented Patrick Verheyen, head of the Johnson & Johnson Innovation centre in London.

Stellar: joining forces to combat neurological diseases

This innovative collaboration will address the funding gap in Flanders for translational projects and will result in relevant neuroprotective therapeutic strategies by enabling multidisciplinary research projects between basic molecular neuroscientists, experts in cognitive animal model testing, clinical neurologists, human imaging specialists and Janssen R&D scientists.

Stellar seeks to attract top researchers in the BeNeLux scientific community to submit proposals for cutting-edge research in neurodegenerative disorders. The Johnson & Johnson companies will collaborate initially with VIB, KU Leuven and The University Hospital Leuven to create opportunities for collaborative research. Other academic institutions are encouraged to join the project as its next phase begins later this year.

For more information about the initiative and the submission process, please visit (available on June 17, 2013).


Contact: Sooike Stoops
VIB (the Flanders Institute for Biotechnology)

Related biology news :

1. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
2. KU Leuven lab coordinates €9m effort to find new deep-sea drugs
3. UC Berkeley, UCSF and Stanford join forces to help commercialize university innovations
4. Molecular forces are key to proper cell division
5. NJIT and Chinese Tech Institute join forces for 2013 Solar Decathlon in China
6. Scientists join forces to bring plant movement to light
7. Social factors trump genetic forces in forging friendships, CU-led study finds
8. Eurofins MWG Operon reinforces NGS capability with Illumina HiSeq 2500 and Illumina MiSeq
9. New forensic institute at the University of Leicester will help police forces solve unusual crimes
10. University of Leeds and Chinese Academy of Sciences join forces
11. Scientists join forces in call for action to save coral reefs
Post Your Comments:
(Date:5/6/2017)... 2017 RAM Group , Singaporean ... breakthrough in biometric authentication based on a ... to perform biometric authentication. These new sensors are based ... by Ram Group and its partners. This sensor will ... chains and security. Ram Group is a next ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont ... today that they have entered into a multiyear collaboration to identify and characterize ... with additional tools for gene editing across all applications. , Under the terms ...
(Date:10/12/2017)... , ... October 12, 2017 ... ... has launched Rosalind™, the first-ever genomics analysis platform specifically designed for life ... Named in honor of pioneering researcher Rosalind Franklin, who made a major ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
Breaking Biology Technology: